Stat News
healthCenter
STAT+: Novartis’ experimental cardiovascular drug fails a pivotal studytranslating…
A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the firm.
Keywords#Novartis’#STAT#cardiovascular drug#pivotal study#novartis
Comments
Sign in to join the discussion.
Loading comments…